Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys Add-on in Chronic HBeAg-negative Hepatitis B (PADD-ON)
NCT01524679Phase 2Completed
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Aug 2012
- Primary completion
- Aug 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Johannes Gutenberg University Mainz. Started Aug 2012; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01524679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01524679.